Dratovis-40

Description

Dratovis-40 is an ANVIS tablet product containing drotaverine hydrochloride 40 mg. The photographed pack contains one strip of ten tablets. This page brings together the labelled product specification and general information about drotaverine, an antispasmodic medicine.

Dratovis-40 product specification

• Product name: Dratovis-40
• Active ingredient: Drotaverine hydrochloride
• Strength: 40 mg
• Dosage form: Tablets
• Pack presentation: 1 × 10 tablets
• Brand: ANVIS

The photograph shows the carton and tablet blister. When matching this presentation to a prescription, check the ingredient, 40 mg strength and tablet form together. The number of tablets in the pack does not determine your daily dose or how long you should take the medicine.

About drotaverine

Drotaverine is an antispasmodic that acts on smooth muscle. Clinicians use it for selected conditions involving spasms, including gastrointestinal colic. The appropriate use depends on the cause of the symptoms, so a healthcare professional should assess unexplained or recurring pain before choosing treatment.

Dratovis-40: precautions before use

Follow the advice of your doctor or pharmacist and the leaflet supplied with your pack. Tell them about other medicines, liver or kidney problems, pregnancy or breastfeeding. Ask about the correct dose and treatment duration instead of selecting a regimen from the pack size.

Drotaverine can cause unwanted effects, including flushing, sweating, palpitations or dizziness. Consult a healthcare professional if symptoms concern you. The product leaflet provides the full list of precautions, interactions and possible side effects.

When abdominal pain needs medical attention

Seek emergency medical care if abdominal pain starts suddenly or becomes severe, or if you vomit blood. Pain that worsens, persists or keeps returning also needs medical assessment. Do not use symptom relief to delay investigating the cause.

Read the NHS guidance on abdominal pain for more information. For product documentation, contact ANVIS with the full name and strength, or browse our tablet catalogue.